Search

Your search keyword '"Richard J Ross"' showing total 270 results

Search Constraints

Start Over You searched for: Author "Richard J Ross" Remove constraint Author: "Richard J Ross" Topic medicine.medical_specialty Remove constraint Topic: medicine.medical_specialty
270 results on '"Richard J Ross"'

Search Results

1. Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia

2. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia

Catalog

Books, media, physical & digital resources

3. Hydrocortisone granules in capsules for opening (Alkindi) as replacement therapy in pediatric patients with adrenal insufficiency

4. Real-World Estimates of Adrenal Insufficiency-Related Adverse Events in Children With Congenital Adrenal Hyperplasia

5. A Prospective Study of Children Aged 0–8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules

6. Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation

7. An oral lipidic native testosterone formulation that is absorbed independent of food

8. Phase 3 and extension study of modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia

9. Surgically treated acromegaly patients have a similar quality of life whether controlled by surgery or requiring additional medical therapy (QuaLAT Study)

12. Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia

13. Surgical Practice in Girls with Congenital Adrenal Hyperplasia: An International Registry Study

14. Response to 'Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia'

15. A Phase III randomized, controlled trial of a modified-release hydrocortisone formulation in the treatment of classic congenital adrenal hyperplasia

16. SAT-396 A Non-Surgical Animal Model of Hypoparathyroidism for Testing PTH Analogues

17. SUN-197 Giant Adrenal Myelolipoma Associated with Prolonged ACTH Elevation in a Patient with Congenital Adrenal Hyperplasia (CAH)

18. MON-170 Real World Estimates of Adrenal Insufficiency Related Adverse Events in Children with Congenital Adrenal Hyperplasia: On Behalf of the I-CAH Consortium

19. Salivary Cortisone to Estimate Cortisol Exposure and Sampling Frequency Required Based on Serum Cortisol Measurements

20. Human studies on hypothalamo-pituitary-adrenal (HPA) axis

21. Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegaly

22. Verbal memory functioning moderates psychotherapy treatment response for PTSD-Related nightmares

23. Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children

24. Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo

25. Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency

26. Exploring trends in the glucocorticoid and mineralocorticoid treatment of congenital adrenal hyperplasia by analysing data from the I-CAH registry

27. Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency

28. Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial

29. Tuberculosis as a differential for bilateral adrenal masses in the UK

30. Optimizing mineralocorticoid replacement therapy in patients with congenital adrenal hyperplasia and Addison's disease

31. MON-537 Fusion of Parathyroid Hormone to Growth Hormone Binding Protein Delays Clearance Whilst Retaining Biological Activity

32. Medical Treatment Achieves Similar Quality of Life to Surgically Treated Acromegaly Patients in Remission: The QuaLAT Study

33. Influence of Sleep Disturbance on Global Functioning After Posttraumatic Stress Disorder Treatment

34. Is physiological glucocorticoid replacement important in children?

35. A model for measuring the health burden of classic congenital adrenal hyperplasia in adults

36. Bioavailability of Oral Hydrocortisone Corrected for Binding Proteins and Measured by LC-MS/MS Using Serum Cortisol and Salivary Cortisone

37. Development of a large adrenal myelolipoma in the context of long-term elevated ACTH

38. The circadian rhythm of corticosteroid-binding globulin has little impact on cortisol exposure after hydrocortisone dosing

39. Accuracy of hydrocortisone dose administration via nasogastric tube

40. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia

41. Adrenal insufficiency in young children : a mixed methods study of parents' experiences

42. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults

43. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers

44. The Microvascular Basis of the Superior Thyroid Artery Perforator Flap

45. Evaluation of adipocytokines and traditional cardiometabolic risk factors in young male cancer survivors: an age-matched control study

46. Immediate-release granule formulation of hydrocortisone, Alkindi®, for treatment of paediatric adrenal insufficiency (Infacort development programme)

47. Growth Hormone Research Society perspective on biomarkers of GH action in children and adults

48. International survey on high- and low-dose synacthen test and assessment of accuracy in preparing low-dose synacthen

49. A Phase 2 Study of Chronocort, a Modified-Release Formulation of Hydrocortisone, in the Treatment of Adults With Classic Congenital Adrenal Hyperplasia

50. Optimal glucocorticoid replacement in adrenal insufficiency